Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae: Implications for Breakpoint Determinations

Cefprozil, an oral semisynthetic cephalosporin, is commonly utilized in the treatment of respiratory-tract infections in children. While this agent has provided acceptable clinical success over a number of years, this study was undertaken to better define its pharmacodynamic profile against Streptoc...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Nicolau, David P., Onyeji, Cyprian O., Zhong, Mingkang, Tessier, Pamela R., Banevicius, Mary Anne, Nightingale, Charles H.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2000
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89857/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1291-1295.2000
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!